Publication | Closed Access
Docetaxel, gemcitabine and bevacizumab as salvage chemotherapy for HER-2-negative metastatic breast cancer
10
Citations
29
References
2014
Year
Salvage ChemotherapyBreast OncologyOncologyPharmacologyBreast CancerPharmacotherapyAnti-cancer AgentCancer TreatmentMedicine
| Year | Citations | |
|---|---|---|
Page 1
Page 1